Regeneron Pharmaceuticals (REGN) Debt to Equity (2007 - 2026)
Regeneron Pharmaceuticals (REGN) debt to equity from Dec 31, 2007 to Mar 31, 2026. The current Regeneron Pharmaceuticals (REGN) debt to equity is 6.32%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Regeneron Pharmaceuticals (REGN)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 6.35% | -6.02% |
| 2024 | 6.76% | -11.45% |
| 2023 | 7.63% | -12.67% |
| 2022 | 8.74% | -17.13% |
| 2021 | 10.55% | -41.21% |
| 2020 | 17.95% | N/A |
| 2019 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2014 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2012 | 0.00% | N/A |
| 2011 | 0.00% | N/A |
| 2010 | 0.00% | N/A |
| 2009 | 0.00% | N/A |
| 2008 | 0.00% | N/A |
| 2007 | 0.00% | N/A |
Comparison Regeneron Pharmaceuticals (REGN) debt to equity with competitors
Regeneron Pharmaceuticals (REGN) debt to equity is 6.32%.